Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts Details-
Title Grant Type Focus Area Country Application Due Date Real World Evidence on the Impact of Early and Appropriate Use of Aztreonam-Avibactam (ATM-AVI)Release Date:Research Inflammation & Immunology Brazil, Chile, India, Italy, South Africa, Spain, United Kingdom Guideline Concordant Care and New Data for Patients with MIBC through la/mUCEducation Oncology USA Clinical Research Studies of Atirmociclib in HR+/HER2- and/or HER2+ Breast CancerRelease Date:Research Oncology Australia, Brazil, Canada, China, France, Germany, Italy, Japan, Korea, Mexico, Spain, Taiwan, USA, United Kingdom Quality Improvement Interventions to Enhance the Care of Patients Infected by MBL-CRE or S. maltophiliaRelease Date:Quality Improvement Inflammation & Immunology Australia, Chile, India, Italy, Spain, United Kingdom Advancing Real-World Evidence in Idiopathic Inflammatory Myopathies Through a German Disease RegistryRelease Date:Research Inflammation & Immunology Germany Real-World Evidence on Clinical Outcomes with ATM-AVI in Adult Patients with Stenotrophomonas maltophilia InfectionsRelease Date:Research Inflammation & Immunology China Real-World Evidence on Clinical Outcomes with Aztreonam-Avibactam (ATM-AVI) in Adult Patients with Limited Treatment OptionsRelease Date:Research Inflammation & Immunology China Tissue Penetration and Correlation with Clinical Outcomes of ATM-AVI in Adult Patients with Limited Treatment OptionsRelease Date:Research Inflammation & Immunology China Advancing Multidisciplinary Care in HemophiliaRelease Date:Quality Improvement Rare Disease China BCMA BsAb Educational Initiatives in 2L+ Relapsed/Refractory Multiple MyelomaRelease Date:Education Oncology USA -
Title Grant Type Focus Area Country Application Due Date Improving the Outpatient Management of Emergency Department Patients with Venous Thromboembolism (VTE)Release Date:Partner: American College of Emergency Physicians (ACEP)Quality Improvement Internal Medicine USA HER2 Expression in Urothelial Carcinoma (UC)Release Date:Education Oncology All Antimicrobial Resistance Testing & Stewardship to Improve Hospitalized Patients’ Health OutcomesRelease Date:Quality Improvement Hospital Benin, Congo, The Democratic Republic Closing the Knowledge Gap in anti-TNF Cycling in Rheumatoid ArthritisRelease Date:Education Inflammation & Immunology USA Increasing Healthcare Professional Skills For COVID-19 Vaccine Discussions That Advocate VaccinationRelease Date:Education Vaccines USA Community Oncology Support for Therapy Management in Multiple Myeloma (MM)Release Date:Education Oncology USA Management of Adults and Adolescents with Alopecia AreataRelease Date:Education Inflammation & Immunology USA Sickle Cell Disease Transition in CareRelease Date:Partner: National Alliance of Sickle Cell CentersQuality Improvement Rare Disease USA 2025 Rheumatology Fellowship – United StatesRelease Date:Fellowship Inflammation & Immunology USA Closing the Knowledge Gap in the Diagnosis and Management of Idiopathic Inflammatory Myopathies (IIM)Release Date:Education Inflammation & Immunology USA Invasive Mold Diseases (IMD) & Treatment OutcomesRelease Date:Research Hospital Australia, Austria, Belgium, China, France, Germany, Greece, Italy, Korea, Netherlands, Spain, Switzerland, United Kingdom Implementing Updated RSV Immunization Recommendations for Older AdultsRelease Date:Education Vaccines USA